PI
IONS icon

PFS Investments’s Ionis Pharmaceuticals IONS Stock Holding History

PFS Investments’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$2.99M Buy
72,791
+15
+0% +$576 0.05% 286
2023
Q1 		$2.71M Buy
72,776
+651
+0.9% +$24.4K 0.05% 276
2022
Q4 		$2.72M Sell
72,125
-3,077
-4% -$129K 0.05% 258
2022
Q3 		$3.33M Buy
75,202
+1,077
+1% +$45.4K 0.06% 217
2022
Q2 		$2.74M Sell
74,125
-936
-1% -$35.3K 0.06% 243
2022
Q1 		$2.78M Sell
75,061
-1,118
-1% -$36.6K 0.05% 253
2021
Q4 		$2.32M Sell
76,179
-663
-0.9% -$20.9K 0.04% 265
2021
Q3 		$2.68M Buy
76,842
+1,127
+1% +$42.5K 0.06% 237
2021
Q2 		$2.94M Buy
75,715
+5,211
+7% +$204K 0.07% 217
2021
Q1 		$3.17M Buy
70,504
+13,330
+23% +$743K 0.08% 197
2020
Q4 		$3.55M Buy
57,174
+8,648
+18% +$431K 0.1% 169
2020
Q3 		$2.3M Buy
48,526
+6,135
+14% +$341K 0.08% 180
2020
Q2 		$2.5M Buy
42,391
+6,228
+17% +$346K 0.09% 149
2020
Q1 		$1.71M Buy
36,163
+7,883
+28% +$439K 0.07% 159
2019
Q4 		$1.71M Buy
28,280
+3,908
+16% +$233K 0.07% 155
2019
Q3 		$1.46M Buy
24,372
+8,728
+56% +$569K 0.06% 129
2019
Q2 		$1.01M Buy
15,644
+10,573
+208% +$747K 0.05% 130
2019
Q1 		$412K Buy
+5,071
New +$327K 0.02% 126

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

PFS Investments's IONS Position: Q2 2023 in Review

PFS Investments increased its Ionis Pharmaceuticals (IONS) stake by 0.02% in Q2 2023, buying an estimated $576 and bringing the position to 72,791 shares worth $2.99M. The position accounts for 0.05% of the portfolio, ranked #286.

PFS Investments first reported a position in IONS in Q1 2019 and has held it in 18 quarters since. The position peaked at $3.55M in Q4 2020. 304 funds tracked by Wall St. Rank hold IONS as of Q2 2023.

  • PFS Investments held 72,791 shares of Ionis Pharmaceuticals worth $2.99M as of Q2 2023.
  • PFS Investments bought 15 Ionis Pharmaceuticals shares in Q2 2023, an estimated $576.
  • Ionis Pharmaceuticals made up 0.05% of PFS Investments's portfolio in Q2 2023, its #286 holding.
  • PFS Investments first reported a position in Ionis Pharmaceuticals in Q1 2019 and has held it in 18 quarters since.
  • PFS Investments's Ionis Pharmaceuticals position peaked at $3.55M in Q4 2020.
  • 304 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2023.

Based on PFS Investments's 13F filing for Q2 2023, filed 14 Aug 2023.